Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.13 is 120% above its 5-year average of 2.33, near the high end of its 5-year range (1.28–5.13).
As of the fiscal period ended Tuesday, June 30, 2026. 34.57% above its 12-month average of 3.81.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.13.
QUICK RATIO (ACID-TEST)
5.13
QUICK RATIO (ACID-TEST) AVG TTM
3.81
QUICK RATIO (ACID-TEST) AVG 3Y
2.83
QUICK RATIO (ACID-TEST) AVG 5Y
2.33
QUICK RATIO (ACID-TEST) AVG 10Y
2.30
QUICK RATIO (ACID-TEST) AVG 15Y
1.81
QUICK RATIO (ACID-TEST) AVG 20Y
1.76
CURRENT VS TTM AVG
+34.57%
CURRENT VS 3Y AVG
+80.85%
CURRENT VS 5Y AVG
+119.78%
CURRENT VS 10Y AVG
+123.32%
CURRENT VS 15Y AVG
+183.38%
CURRENT VS 20Y AVG
+190.84%
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+53.01%
vs the sector median at left
Niagen Bioscience Inc
Market Cap
$213.84M
Quick Ratio (Acid-Test)
5.13
TTM Avg
3.81
3Y Avg
2.83
5Y Avg
2.33
Market Cap
$213.86M
Quick Ratio (Acid-Test)
5.36
TTM Avg
6.17
3Y Avg
11.50
5Y Avg
11.99
Market Cap
$214.64M
Quick Ratio (Acid-Test)
4.07
TTM Avg
3.65
3Y Avg
6.88
5Y Avg
10.38
Market Cap
$210.68M
Quick Ratio (Acid-Test)
344.31
TTM Avg
177.51
3Y Avg
95.13
5Y Avg
76.52
Market Cap
$211.80M
Quick Ratio (Acid-Test)
5.72
TTM Avg
5.91
3Y Avg
5.85
5Y Avg
7.15
Market Cap
$210.80M
Quick Ratio (Acid-Test)
10.89
TTM Avg
11.84
3Y Avg
8.89
5Y Avg
15.32
Market Cap
$208.20M
Quick Ratio (Acid-Test)
2.45
TTM Avg
2.08
3Y Avg
1.84
5Y Avg
1.77
Market Cap
$208.98M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$222.26M
Quick Ratio (Acid-Test)
21.96
TTM Avg
18.45
3Y Avg
17.11
5Y Avg
21.15
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Niagen Bioscience Inc (NAGE) | $213.84M | 5.13 | 3.81 | 2.83 | 2.33 |
| Lyell Immunopharma, Inc. (LYEL)vs › | $213.86M | 5.36 | 6.17 | 11.50 | 11.99 |
| Prelude Therapeutics Incorporated (PRLD)vs › | $214.64M | 4.07 | 3.65 | 6.88 | 10.38 |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $210.68M | 344.31 | 177.51 | 95.13 | 76.52 |
| Compugen Ltd. (CGEN)vs › | $211.80M | 5.72 | 5.91 | 5.85 | 7.15 |
| Entrada Therapeutics, Inc. (TRDA)vs › | $210.80M | 10.89 | 11.84 | 8.89 | 15.32 |
| Pro-Dex, Inc. (PDEX)vs › | $208.20M | 2.45 | 2.08 | 1.84 | 1.77 |
| Electra Therapeutics Inc. (ETRA)vs › | $208.98M | N/A | N/A | N/A | N/A |
| Keros Therapeutics, Inc. (KROS)vs › | $222.26M | 21.96 | 18.45 | 17.11 | 21.15 |
| Sionna Therapeutics, Inc. (SION)vs › | $206.11M | 20.05 | 17.55 | 12.54 | 12.54 |
Quick Ratio
5.13
Excludes inventory
Current Ratio
6.50
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.13 |
| 2026-03-31 | 3.55 |
| 2025-12-31 | 3.83 |
| 2025-09-30 | 3.29 |
| 2025-06-30 | 3.24 |
| 2025-03-31 | 3.12 |
| 2024-12-31 | 3.06 |
| 2024-09-30 | 2.35 |
| 2024-06-30 | 2.12 |
| 2024-03-31 | 1.88 |
| 2023-12-31 | 1.70 |
| 2023-09-30 | 1.78 |
| 2023-06-30 | 1.81 |
| 2023-03-31 | 1.88 |
| 2022-12-31 | 1.78 |
| 2022-09-30 | 1.33 |
| 2022-06-30 | 1.28 |
| 2022-03-31 | 1.56 |
| 2021-12-31 | 2.00 |
| 2021-09-30 | 2.26 |
| 2021-06-30 | 2.82 |
| 2021-03-31 | 2.55 |
| 2020-12-31 | 1.25 |
| 2020-09-30 | 1.51 |
| 2020-06-30 | 1.46 |
| 2020-03-31 | 1.24 |
| 2019-12-31 | 1.46 |
| 2019-09-30 | 2.41 |
| 2019-06-30 | 1.11 |
| 2019-03-31 | 1.68 |
| 2018-12-31 | 1.96 |
| 2018-09-30 | 2.65 |
| 2018-06-30 | 3.65 |
| 2018-03-31 | 4.71 |
| 2017-12-31 | 6.35 |
| 2017-09-30 | 4.11 |
| 2017-06-30 | 3.13 |
| 2017-03-31 | 0.62 |
| 2016-12-31 | 0.88 |
| 2016-09-30 | 1.44 |
| 2016-06-30 | 2.22 |
| 2016-03-31 | 1.15 |
| 2015-12-31 | 0.87 |
| 2015-09-30 | 1.51 |
| 2015-06-30 | 1.83 |
| 2015-03-31 | 1.22 |
| 2014-12-31 | 1.24 |
| 2014-09-30 | 1.12 |
| 2014-06-30 | 0.93 |
| 2014-03-31 | 1.21 |
| 2013-12-31 | 1.26 |
| 2013-09-30 | 0.60 |
| 2013-06-30 | 1.29 |
| 2013-03-31 | 1.13 |
| 2012-12-31 | 0.57 |
| 2012-09-30 | 0.73 |
| 2012-06-30 | 0.88 |
| 2012-03-31 | 1.77 |
| 2011-12-31 | 0.61 |
| 2011-09-30 | 1.39 |
| 2011-06-30 | 1.62 |
| 2011-03-31 | 2.44 |
| 2010-12-31 | 3.05 |
| 2010-09-30 | 2.83 |
| 2010-06-30 | 3.56 |
| 2010-03-31 | 0.58 |
| 2009-12-31 | 0.50 |
| 2009-09-30 | 0.51 |
| 2009-06-30 | 0.52 |
| 2009-03-31 | 0.64 |
| 2008-12-31 | 0.77 |
| 2008-09-30 | 1.05 |
| 2008-06-30 | 0.97 |
| 2008-02-29 | 0.17 |
| 2007-11-30 | 1.45 |
| 2007-08-31 | 8.44 |
| 2007-05-31 | 17.02 |
| 2007-02-28 | 21.08 |
